4.5 Article

AAOS Research Symposium Updates and Consensus: Biologic Treatment of Orthopaedic Injuries

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.5435/JAAOS-D-16-00086

Keywords

-

Funding

  1. Arthrex
  2. Ossur
  3. Smith Nephew
  4. ConMed Linvatec
  5. Aesculap/B. Braun Medical
  6. Aperion Biologics
  7. Becton Dickinson
  8. DePuy Synthes
  9. Genzyme
  10. Moximed
  11. RNL Bio

Ask authors/readers for more resources

Strategies that seek to enhance musculoskeletal tissue regeneration and repair by modulating the biologic microenvironment at the site of injury have copsiderable therapeutic potential. Current and emerging biologic approaches include the use of growth factors, platelet-rich plasma, stem cell therapy, and scaffolds,The American Academy of Orthopaedic Surgeons hosted a research symposium in November 2015 to review the current state-of-the-art biologic treatments of articular cartilage, muscle, tendon; and bone injuries and identify knowledge gaps related to these emerging treatments This review outlines the findings of the symposium and summarizes the, consensus reached on how best to advance research on biologic treatment of orthopaedic injuries.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available